Massachusetts Financial Services
FPRX

Massachusetts Financial Services’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Massachusetts Financial Services’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-19,531
Closed -$1.02M – 905
2016
Q3 		$1.02M Buy
19,531
+4,540
+30% +$217K ﹤0.01% 758
2016
Q2 		$620K Buy
+14,991
New +$652K ﹤0.01% 765

Other funds holding FPRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Massachusetts Financial Services's FPRX Position: Q4 2016 in Review

Massachusetts Financial Services sold out of Five Prime Therapeutics, Inc. (FPRX) in Q4 2016, closing a stake of 19,531 shares — an estimated $1.02M sold.

Massachusetts Financial Services first reported a position in FPRX in Q2 2016 and held it in 2 quarters. The position peaked at $1.02M in Q3 2016. 172 funds tracked by Wall St. Rank hold FPRX as of Q4 2016.

  • Massachusetts Financial Services reported no remaining Five Prime Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
  • Massachusetts Financial Services sold 19,531 Five Prime Therapeutics, Inc. shares in Q4 2016, an estimated $1.02M.
  • Massachusetts Financial Services first reported a position in Five Prime Therapeutics, Inc. in Q2 2016 and held it in 2 quarters.
  • Massachusetts Financial Services's Five Prime Therapeutics, Inc. position peaked at $1.02M in Q3 2016.
  • 172 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q4 2016.

Based on Massachusetts Financial Services's 13F filing for Q4 2016, filed 13 Feb 2017.